Praxis Precision Medicines PRAX
NASDAQ PRAX
$300.65 +1.78 (+0.60%)
At close: Sep 22, 2026 · 4:00 PM EDT

Praxis Precision Medicines (PRAX) Cash & Equivalents Growth (5y) (2024 - 2026)

Analysis

Praxis Precision Medicines (PRAX) Cash & Equivalents Growth (5y) (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 212.54 Bn 198.55 Bn 7.24 Bn
2 Gilead Sciences 186.84 Bn 183.58 Bn 6.22 Bn
3 Vertex Pharmaceuticals 129.39 Bn 121.54 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.05 Bn 74.06 Bn 3.93 Bn
5 Moderna 69.00 Bn 63.87 Bn 52.00 Mn
6 Argenx Se 61.15 Bn 55.97 Bn 1.37 Bn
7 Alnylam Pharmaceuticals 32.67 Bn 29.37 Bn 992.69 Mn
8 Biogen 32.37 Bn 31.08 Bn 1.96 Bn
9 Roivant Sciences 28.18 Bn 28.87 Bn 1.16 Mn
10 Praxis Precision Medicines 8.34 Bn 7.58 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 21.97%
Mar 31, 2026 32.54%
Dec 31, 2025 3.80%
Sep 30, 2025 5.43%
Jun 30, 2025 51.46%
Mar 31, 2025 92.61%
Dec 31, 2024 36.88%
Sep 30, 2024 108.11%
API Access

Praxis Precision Medicines Cash & Equivalents Growth (5y) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents-growth-5y&ticker=PRAX&period=max&api_key=YOUR_API_KEY